Search

everythinglearnresearchcommunity

for

Search:↓

Minoxidil and ranolazine together can reduce the spread of certain breast cancer cells.

A new method using gold nanoshells and infrared light effectively delivers siRNA to cancer and stem cells with precision and minimal damage.

KGF and its receptor are found in enlarged prostate tissue and KGF strongly increases cell growth.

Repurposing existing drugs and using micronutrients may effectively target cancer stem cells and improve cancer treatment.

Birth control pills increase certain receptor activities in female gerbil prostate glands and can lead to prostate changes.

Phytochemicals may offer safer alternatives to synthetic drugs for prostate cancer treatment.

Androgen signaling reduces Wnt activity, affecting prostate stem cell growth.

SARMs may be an effective treatment for a certain type of breast cancer by blocking cancer growth and spread.

Overexpressing SSAT enzyme reduces prostate tumor growth in mice.

Finasteride helps increase or maintain hair in most men but can cause sexual side effects and should not be used by women, especially during pregnancy.

Dehydroepiandrosterone (DHEA) is a prohormone important for producing sex steroids and has potential health benefits.

5α-reductase is essential for male sexual development and its inhibitors have potential in treating various conditions related to hormone action.

Antiandrogens have important biological effects, but more research is needed to understand them fully and compare their effectiveness and side effects to other treatments.

The structure of SRD5A reveals how it reduces steroids, aiding drug design for related health conditions.

PSA testing is a reliable method for detecting prostate cancer, and opioids may lower PSA levels, but triglycerides don't affect prostate cancer risk.

Higher urethral PSA levels after prostate removal surgery may be linked to more hair loss and higher PSA levels post-surgery.

A new compound was made that might help treat diseases related to male hormones.

Certain drugs that block specific enzymes can help treat prostate diseases.

Some plant-derived compounds may help with hormonal conditions, but more research is needed to confirm their effectiveness.

ERβ has potential in treating prostate cancer and neurodegenerative diseases, but human studies are needed before clinical use.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

The main prostate diseases in dogs are benign growth, infections, and cancer, with various treatments ranging from drugs to surgery, but cancer treatments have limited success.

The document concludes that the 5 alpha-reductase enzymes are important in steroid metabolism and related to various human diseases, with inhibitors used to treat conditions like male pattern baldness and prostate issues.

There is no clear recommendation for using selenium in cancer patients; it may be beneficial to correct low selenium levels before treatment.

The length of the CAG repeat in the androgen receptor gene affects the risk and progression of prostate cancer, BPH, infertility, and undermasculinized genitalia.

DHT is a strong androgen that may pose less risk to the prostate compared to testosterone.

Androgens and SARMs play a role in body mass, frailty, skin health, and hair growth, and are used in treating prostate cancer, acne, and hair loss, with potential for new uses and improved versions in the future.

AGA affects many, progresses differently, and early treatment is crucial.

Using two drugs together, Flutamide and 4-MA, is more effective for blocking male hormones than using each one alone.

Balding and low testosterone increase risk of urinary stones.